These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 271271)

  • 1. Cellular distribution of hemoglobin F in a clonal hemopoietic stem-cell disorder.
    Papayannopoulou T; Bunn HF; Stamatoyannopoulos G
    N Engl J Med; 1978 Jan; 298(2):72-5. PubMed ID: 271271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of sickle cell disease as shown by density profiles: effects of fetal hemoglobin and alpha thalassemia.
    Baudin V; Pagnier J; Labie D; Girot R; Wajcman H
    Haematologia (Budap); 1986; 19(3):177-84. PubMed ID: 2430866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
    Noguchi CT; Dover GJ; Rodgers GP; Serjeant GR; Antonarakis SE; Anagnou NP; Higgs DR; Weatherall DJ; Schechter AN
    J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cells on stems.
    Desforges JF
    N Engl J Med; 1978 Jan; 298(2):104. PubMed ID: 271269
    [No Abstract]   [Full Text] [Related]  

  • 5. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal hemoglobin analysis of erythroid bursts in patients with chronic myelogenous leukemia (CML).
    Strobel ES; Messner HA; Löhr GW; Fauser AA
    Exp Hematol; 1983 Nov; 11(10):982-6. PubMed ID: 6198197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells.
    Fialkow PJ; Denman AM; Jacobson RJ; Lowenthal MN
    J Clin Invest; 1978 Oct; 62(4):815-23. PubMed ID: 308953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.
    Embury SH; Dozy AM; Miller J; Davis JR; Kleman KM; Preisler H; Vichinsky E; Lande WN; Lubin BH; Kan YW; Mentzer WC
    N Engl J Med; 1982 Feb; 306(5):270-4. PubMed ID: 6172710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute nonlymphocytic leukemia: expression in cells restricted to granulocytic and monocytic differentiation.
    Fialkow PJ; Singer JW; Adamson JW; Berkow RL; Friedman JM; Jacobson RJ; Moohr JW
    N Engl J Med; 1979 Jul; 301(1):1-5. PubMed ID: 286882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of alpha-thalassemia and homozygous sickle-cell disease.
    Higgs DR; Aldridge BE; Lamb J; Clegg JB; Weatherall DJ; Hayes RJ; Grandison Y; Lowrie Y; Mason KP; Serjeant BE; Serjeant GR
    N Engl J Med; 1982 Jun; 306(24):1441-6. PubMed ID: 6176865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
    Perrine SP; Ginder GD; Faller DV; Dover GH; Ikuta T; Witkowska HE; Cai SP; Vichinsky EP; Olivieri NF
    N Engl J Med; 1993 Jan; 328(2):81-6. PubMed ID: 7677966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.
    Veith R; Galanello R; Papayannopoulou T; Stamatoyannopoulos G
    N Engl J Med; 1985 Dec; 313(25):1571-5. PubMed ID: 2415821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of fetal hemoglobin production.
    Kazazian HH
    Semin Hematol; 1974 Oct; 11(4):525-48. PubMed ID: 4608465
    [No Abstract]   [Full Text] [Related]  

  • 16. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
    Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
    Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type.
    Nagel RL; Fabry ME; Pagnier J; Zohoun I; Wajcman H; Baudin V; Labie D
    N Engl J Med; 1985 Apr; 312(14):880-4. PubMed ID: 2579336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual variation in the production and survival of F cells in sickle-cell disease.
    Dover GJ; Boyer SH; Charache S; Heintzelman K
    N Engl J Med; 1978 Dec; 299(26):1428-35. PubMed ID: 101847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
    Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of erythrocytes that contain fetal hemoglobin in anemia. Transient in vivo changes.
    Dover GJ; Boyer SH; Zinkham WH
    J Clin Invest; 1979 Feb; 63(2):173-6. PubMed ID: 429549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.